How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
58
NHI Quote, Financials, Valuation and Earnings
Last price:
$82.15
Seasonality move
:
-0.33%
Day range:
$80.06 - $82.34
52-week range:
$65.22 - $82.34
Dividend yield:
4.43%
P/E ratio:
25.88x
P/S ratio:
10.64x
P/B ratio:
2.64x
Volume:
334.6K
Avg. volume:
208.3K
1-year change:
20.34%
Market cap:
$3.9B
Revenue:
$338.1M
EPS (TTM):
$3.17
Analysts' Opinion
-
Consensus RatingNational Health Investors, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $85.63, National Health Investors, Inc. has an estimated upside of 4.27% from its current price of $82.12.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $77.00 representing 100% downside risk from its current price of $82.12.
Fair Value
-
According to the consensus of 8 analysts, National Health Investors, Inc. has 4.27% upside to fair value with a price target of $85.63 per share.
NHI vs. S&P 500
-
Over the past 5 trading days, National Health Investors, Inc. has overperformed the S&P 500 by 3.05% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
National Health Investors, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
National Health Investors, Inc. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter National Health Investors, Inc. reported revenues of $90.6M.
Earnings Growth
-
National Health Investors, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter National Health Investors, Inc. reported earnings per share of $0.69.
Enterprise value:
5B
EV / Invested capital:
--
Price / LTM sales:
10.64x
EV / EBIT:
25.75x
EV / Revenue:
13.83x
PEG ratio (5yr expected):
2.83x
EV / Free cash flow:
23.32x
Price / Operating cash flow:
17.94x
Enterprise value / EBITDA:
18.13x
Gross Profit (TTM):
$218.1M
Return On Assets:
5.5%
Net Income Margin (TTM):
40.67%
Return On Equity:
10.31%
Return On Invested Capital:
5.67%
Operating Margin:
48.82%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $312.9M | $331.8M | $358.5M | $83.7M | $90.6M | |
| Gross Profit | $190.5M | $206.4M | $218.1M | $51.6M | $50.8M | |
| Operating Income | $170.7M | $186.2M | $192.5M | $46.8M | $44.2M | |
| EBITDA | $242.7M | $258.9M | $273.4M | $65.2M | $65.2M | |
| Diluted EPS | $2.43 | $2.91 | $3.17 | $0.65 | $0.69 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $450.3M | $350.5M | $354M | $340.1M | $381.2M | |
| Total Assets | $2.9B | $2.5B | $2.5B | $2.5B | $2.7B | |
| Current Liabilities | $71.1M | $62.1M | $118.5M | $72.2M | $253.5M | |
| Total Liabilities | $1.4B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Total Equity | $1.5B | $1.3B | $1.3B | $1.2B | $1.5B | |
| Total Debt | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $180.1M | $204.3M | $228.4M | $48.6M | $62.6M | |
| Cash From Investing | -$62.7M | -$29.6M | -$243.9M | -$1.6M | $41.8M | |
| Cash From Financing | -$130.6M | -$175.5M | $79.4M | -$46.2M | -$42.1M | |
| Free Cash Flow | $174.1M | $192.4M | $212.5M | $44M | $57.6M | |
NHI
Sector
Market Cap
$3.9B
$979.2M
Price % of 52-Week High
99.73%
89.36%
Dividend Yield
4.43%
2.41%
Shareholder Yield
-2.63%
3.31%
1-Year Price Total Return
20.34%
--
Beta (5-Year)
0.667
0.617
Dividend yield:
4.43%
Annualized payout:
$3.60
Payout ratio:
133.53%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$80.00
200-day SMA
Buy
Level
$75.46
Bollinger Bands (100)
Buy
Level
75.56 - 79.44
Chaikin Money Flow
Buy
Level
470.8K
20-day SMA
Buy
Level
$78.88
Relative Strength Index (RSI14)
Buy
Level
62.97
ADX Line
Buy
Level
13.78
Williams %R
Sell
Level
-3.8596
50-day SMA
Buy
Level
$78.33
MACD (12, 26)
Buy
Level
11.53
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
543.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.7099)
Buy
CA Score
(Annual)
Level (-0.0168)
Buy
Beneish M-Score
(Annual)
Level (-3.3065)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.2733)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities. The SHOP segment is involved in two ventures that own the operations of independent living facilities. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.
Stock Forecast FAQ
In the current month, NHI has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The NHI average analyst price target in the past 3 months is $85.63.
-
Where Will National Health Investors, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that National Health Investors, Inc. share price will rise to $85.63 per share over the next 12 months.
-
What Do Analysts Say About National Health Investors, Inc.?
Analysts are divided on their view about National Health Investors, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that National Health Investors, Inc. is a Sell and believe this share price will drop from its current level to $77.00.
-
What Is National Health Investors, Inc.'s Price Target?
The price target for National Health Investors, Inc. over the next 1-year time period is forecast to be $85.63 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is NHI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for National Health Investors, Inc. is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NHI?
You can purchase shares of National Health Investors, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase National Health Investors, Inc. shares.
-
What Is The National Health Investors, Inc. Share Price Today?
National Health Investors, Inc. was last trading at $82.15 per share. This represents the most recent stock quote for National Health Investors, Inc.. Yesterday, National Health Investors, Inc. closed at $82.12 per share.
-
How To Buy National Health Investors, Inc. Stock Online?
In order to purchase National Health Investors, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NHI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NHI
Sector
P/E ratio
25.88x
17.46x
PEG ratio
2.83x
0.05x
P/B ratio
2.64x
0.83x
Price / LTM sales
10.64x
3.22x
Growth Metrics
NHI
Sector
Revenue growth
8.25%
3.09%
Earnings growth
6.29%
3.69%
Revenue (5-year growth)
1.23%
2.84%
Earnings forecast
$0.81
$0.14
Profitability
NHI
Sector
Profitability FY 2024
$210.3M
$153.7M
Return on invested capital
5.67%
2%
Return on assets
5.5%
1.81%
Return on equity
10.31%
3.5%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
NHI
Sector
Total cash
$81.6M
$73.7M
Short term investments
--
$11.9M
Total assets
$2.6B
$3.2B
Long term debt
$1.1B
$343.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
40
GDXU alert for Jan 31
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Sell
34
PFSI alert for Jan 31
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Sell
40
SHNY alert for Jan 31
MicroSectors Gold 3X Leveraged ETN [SHNY] is down 31.56% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
